| Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu … ABM Kharsany, C Cawood, D Khanyile, A Grobler, LR Mckinnon, ... BMC public health 15, 1-11, 2015 | 51 | 2015 |
| Characterization of HIV-1 gag and nef in Cameroon: further evidence of extreme diversity at the origin of the HIV-1 group M epidemic M Tongo, DP Martin, L Zembe, E Mpoudi-Ngole, C Williamson, ... Virology journal 10, 1-7, 2013 | 30 | 2013 |
| Temporal association of HLA-B* 81: 01-and HLA-B* 39: 10-mediated HIV-1 p24 sequence evolution with disease progression RS Ntale, DR Chopera, NK Ngandu, D Assis de Rosa, L Zembe, ... Journal of virology 86 (22), 12013-12024, 2012 | 28 | 2012 |
| Population sizes, HIV prevalence, and HIV prevention among men who paid for sex in sub-Saharan Africa (2000–2020): A meta-analysis of 87 population-based surveys C Hodgins, J Stannah, S Kuchukhidze, L Zembe, JW Eaton, MC Boily, ... PLoS medicine 19 (1), e1003861, 2022 | 16 | 2022 |
| Intra-and inter-clade cross-reactivity by HIV-1 Gag specific T-cells reveals exclusive and commonly targeted regions: implications for current vaccine trials L Zembe, WA Burgers, HB Jaspan, LG Bekker, H Bredell, G Stevens, ... PloS one 6 (10), e26096, 2011 | 16 | 2011 |
| Estimating male circumcision coverage in 15 priority countries in sub‐Saharan Africa PM Stegman, R Yee, J Davis, M Tchuenche, R Linder, L Zembe, ... Journal of the International AIDS Society 24, e25789, 2021 | 7 | 2021 |
| Striking lack of T cell immunodominance in both a multiclade and monoclade HIV-1 epidemic: Implications for vaccine development M Tongo, L Zembe, E Ebong, S Roux, LG Bekker, C Williamson, ... Vaccine 32 (20), 2328-2336, 2014 | 5 | 2014 |
| Spatio-temporal estimates of HIV risk group proportions for adolescent girls and young women across 13 priority countries in sub-Saharan Africa A Howes, KA Risher, VK Nguyen, O Stevens, KM Jia, TM Wolock, RT Esra, ... PLOS Global Public Health 3 (4), e0001731, 2023 | 3 | 2023 |
| Defining the Global Research and Programmatic Agenda and Priority Actions for Voluntary Medical Male Circumcision for HIV Prevention ME Peck, T Lucas, KS Ong, JM Grund, S Davis, A Yansaneh, ... Current HIV/AIDS Reports 19 (6), 537-547, 2022 | 3 | 2022 |
| Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa A Ericsen, M Lauck, M Mohns, S Dinapoli, J Mutschler, J Greene, ... Journal of the International AIDS Society 19 (6 Suppl 5), 21264, 2016 | 3 | 2016 |
| AIDS Vaccine 2013October 7–10, 2013Barcelona, Spain T Hertz AIDS Research and Human Retroviruses 29 (11), A-1, 2013 | 1 | 2013 |
| The Immune Respons to HIV MC Gray, P Gumbi, L Zembe, M Radebe, B Walker Sande’s HIV/AIDS Medicine, Elseviers, 45-57, 2012 | 1 | 2012 |
| Interventions to improve men’s engagement in HIV and other key services in sub-Saharan Africa: a scoping review K Dovel, J Hubbard, L Zembe, N Ford, M Cornell, W Belshe, L Long, ... medRxiv, 2023.10. 25.23297534, 2023 | | 2023 |
| TUAC0201 [LINE SEPARATOR] Strengthening HIV surveillance in the antiretroviral therapy era: baseline findings of HIV prevalence and incidence from KwaZulu‐Natal, South Africa A Kharsany, C Cawood, D Khanyile, A Grobler, A Puren, T Kufa‐Chakeza, ... African Journal of Reproduction and Gynaecological Endoscopy 19, 2016 | | 2016 |
| Strengthening HIV surveillance in the antiretroviral therapy era: baseline findings of HIV prevalence and incidence from KwaZulu-Natal, South Africa A Kharsany, C Cawood, D Khanyile, A Grobler, A Puren, T Kufa-Chakeza, ... JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 19, 2016 | | 2016 |
| HPTN 069/ACTG A5305: phase II study of maraviroc-containing regimens for HIV PrEP in US women; Postive impact of a randomized controlled trial of the Uthando Lwethu (" Our Love … A Ericsen, M Lauck, M Mohns, S Dinapoli, J Mutschler, J Greene, ... | | 2016 |
| Immunodominance of HIV-1 Consensus M Gag and Nef Peptides in a Mono-and Multiclade Epidemic: Implications for Vaccine Design and Testing M Tongo, L Zembe, E Ebong, EM Ngole, C Williamson, WA Burgers AIDS RESEARCH AND HUMAN RETROVIRUSES 29 (11), A150-A151, 2013 | | 2013 |
| The recognition of HIV-1 consensus group M Gag and Nef peptide reagents in mono-and multi-clade epidemics: implications for HIV vaccine design L Zembe, M Tongo, E Ebong, EM Ngobe, C Williamson, W Burgers Retrovirology 9, 1-1, 2012 | | 2012 |
| Investigating cross-clade immune responses in HIV-1 subtype C-infected individuals from South Africa: Implications for HIV Vaccine Design L Zembe | | 2012 |
| P16-44. Investigating T cell immune responses in Cameroon, a country with broad HIV-1 genetic diversity M Tongo, E Ebong, L Zembe, EM Ngole, W Burgers Retrovirology 6 (Suppl 3), P273, 2009 | | 2009 |
